secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcellx, Inc. (ACLX)
CIK:        0001786205
Form:       8-K
Filed at:   2022-05-16T23:59:59+00:00
Accession:  0001193125-22-151768
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcellx appoints Olivia Ware to board, replacing Lewis T. Williams effective May 16
--------------------------------------------------------------------------------

- Lewis T. Williams resigned from board effective May 16, 2022; no disagreement cited.
- Board reduced authorized size from nine to seven directors on May 15.
- Olivia Ware appointed as Class II director effective May 16, term until 2024 annual meeting.
- Ware brings over 20 years biopharma experience; previously SVP at Principia, Genentech veteran.
- Ware receives $40k annual cash retainer, $4k for nominating committee, initial option grant valued at $600k.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1786205/000119312522151768/0001193125-22-151768-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1786205/000119312522151768/d355647d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-151768

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer